Filing Details

Accession Number:
0001708138-17-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-19 16:44:26
Reporting Period:
2017-06-15
Filing Date:
2017-06-19
Accepted Time:
2017-06-19 16:44:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1391382 J Robert Terifay 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-15 48,750 $52.03 72,043 No 4 M Direct
Common Stock Disposition 2017-06-15 5,411 $468.69 66,632 No 4 F Direct
Common Stock Disposition 2017-06-15 22,192 $468.69 44,440 No 4 F Direct
Common Stock Disposition 2017-06-16 21,147 $468.19 23,293 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-06-15 48,750 $0.00 48,750 $52.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,579 2021-12-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,699 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.